DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 119 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $967,676 | -54.7% | 90,947 | -55.5% | 0.01% | -50.0% |
| Q3 2022 | $2,135,000 | +45.9% | 204,515 | +76.0% | 0.01% | +33.3% |
| Q2 2022 | $1,463,000 | +48.2% | 116,213 | +27.6% | 0.01% | +12.5% |
| Q1 2022 | $987,000 | -72.3% | 91,074 | -64.1% | 0.01% | -76.5% |
| Q4 2021 | $3,565,000 | +54.7% | 253,407 | +111.2% | 0.03% | +17.2% |
| Q3 2021 | $2,305,000 | +627.1% | 119,990 | +272.7% | 0.03% | +625.0% |
| Q2 2021 | $317,000 | -39.8% | 32,199 | -40.0% | 0.00% | -42.9% |
| Q1 2021 | $527,000 | -5.6% | 53,657 | -58.5% | 0.01% | -12.5% |
| Q3 2020 | $558,000 | +23.5% | 129,205 | +63.3% | 0.01% | 0.0% |
| Q4 2019 | $452,000 | +1059.0% | 79,098 | +625.2% | 0.01% | +700.0% |
| Q3 2019 | $39,000 | -84.1% | 10,907 | -82.3% | 0.00% | -80.0% |
| Q2 2019 | $246,000 | -18.3% | 61,585 | +49.8% | 0.01% | -50.0% |
| Q1 2019 | $301,000 | +33.2% | 41,109 | +66.5% | 0.01% | -9.1% |
| Q4 2018 | $226,000 | +22.2% | 24,694 | +65.6% | 0.01% | +10.0% |
| Q3 2018 | $185,000 | +3600.0% | 14,914 | +4286.5% | 0.01% | – |
| Q2 2018 | $5,000 | -95.4% | 340 | -93.7% | 0.00% | -100.0% |
| Q1 2018 | $108,000 | +74.2% | 5,420 | +64.5% | 0.01% | +100.0% |
| Q4 2017 | $62,000 | -46.6% | 3,295 | -39.0% | 0.00% | -50.0% |
| Q3 2017 | $116,000 | +14.9% | 5,404 | -48.5% | 0.01% | 0.0% |
| Q2 2017 | $101,000 | +152.5% | 10,493 | +54.5% | 0.01% | +100.0% |
| Q1 2017 | $40,000 | -63.0% | 6,793 | -34.0% | 0.00% | -57.1% |
| Q3 2016 | $108,000 | +2600.0% | 10,286 | +3981.7% | 0.01% | – |
| Q2 2016 | $4,000 | -33.3% | 252 | -21.0% | 0.00% | – |
| Q1 2016 | $6,000 | -98.9% | 319 | -98.5% | 0.00% | -100.0% |
| Q3 2015 | $539,000 | -28.4% | 21,963 | -31.7% | 0.03% | -27.0% |
| Q2 2015 | $753,000 | +47.6% | 32,148 | +41.5% | 0.04% | +48.0% |
| Q1 2015 | $510,000 | – | 22,727 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |